NEWEST CONTENT
-
ORIGINAL REPORTSTota et al.November 30, 2023
-
ORIGINAL REPORTSBrivio et al.November 30, 2023
-
COMMENTS AND CONTROVERSIESUprety et al.November 30, 2023
-
ART OF ONCOLOGYSymonNovember 28, 2023
-
COMMENTS AND CONTROVERSIESRossig et al.November 27, 2023
FEATURED CONTENT
ORIGINAL REPORTS
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials
Sheng et al. | November 21, 2023
ORIGINAL REPORTS
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer
Rudin et al. | November 17, 2023
SPONSORED CONTENT
Sponsored by LILLY MEDICAL AFFAIRS
Treatment Considerations for Relapsed or Refractory Mantle Cell Lymphoma
MOST READ
(Last 60 days)-
McCullough
-
LoConte et al.
-
Schneider et al.
-
Hoimes et al.